Label

How We Work

Grant

Back

Print

University of Washington Foundation


July 2007
to conduct a placebo-controlled proof-of-concept phase III trial of the safety and efficacy of TDF and FTC/TDF in reducing HIV acquisition among HIV-negative partners within heterosexual HIV-discordant couples
$69,847,223
114
HIV
GLOBAL|AFRICA
Global Health
Seattle, Washington
http://www.washington.edu/foundation/

Visit Our Blog